title: Isolation and characterization of the human cellular myc gene product.
abstract: Antibodies against the product of the human cellular myc gene (c-myc) were prepared against a bacterially expressed human c-myc protein by inserting the ClaI/BclI fragment of the human c-myc DNA clone in an expression vector derived from pPLc24. These antibodies cross-react with viral-coded myc (v-myc) proteins from MC29 and OK10 viruses. Furthermore, IgGs specific for synthetic peptides, corresponding to the 12 carboxy-terminal amino acids of the human c-myc gene and 16 internal amino acids, were isolated. By use of the various myc-specific antisera or IgGs, a protein of Mr 64 000 was detected in several human tumor cell lines including Colo320, small cell cancer of the lung (417d), HL60, Raji, and HeLa. This protein is larger than the corresponding v-myc or chicken c-myc proteins from avian virus transformed cells or avian bursa lymphoma cells (RP9), both of which are proteins of Mr 55 000. The human c-myc protein is located in the nucleus of Colo320 cells, exhibits a half-life of about 15 min, and is expressed at significantly lower levels than the viral protein. The human c-myc protein was enriched about 3000-fold from Colo320 cells using c-myc-specific IgG coupled to Sepharose beads. The protein binds to double-stranded DNA in vitro, a reaction that can be inhibited to more than 90% by c-myc specific IgG.
mesh_terms: D000906:Antibodies; D002460:Cell Line; D003001:Cloning, Molecular; D004262:DNA Restriction Enzymes; D006801:Humans; D007700:Kinetics; D009363:Neoplasm Proteins / Q000235:genetics / Q000302:isolation & purification*; D009369:Neoplasms; D009857:Oncogenes; D010957:Plasmids
chemical_list: D000906:Antibodies; D009363:Neoplasm Proteins; D004262:DNA Restriction Enzymes